Clinical trial · Observational
Measuring the Spectrum of Tissues During Endoscopy
NCT00996619CI-TRIAL-00002715unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lesions, polyps and other abnormalities in the gastrointestinal (GI) tract have a different composition compared to the normal mucose. The investigators plan to gather spectroscopic information from these features. Characterizing their unique spectrums, may help to enhance the detection and identification of these objects during endoscopy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Carcinoma | Colon Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Colonic Polyps | — | UNRESOLVED | — |
| Intestinal Polyps | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| An optical fiber, inside the work channel of an endoscope, is added to the endoscopic examination | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- People undergoing GI tract endoscopy
- interventionNames
- Procedure: An optical fiber, inside the work channel of an endoscope, is added to the endoscopic examination
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult, independent patients who come to Sheba Hospital's gastro-intestinal clinic for endoscopy and are willing to sign an informed consent Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.